Publication number: 20250129717
Abstract: A quantitative prediction method for gas content of deep marine shale includes: obtaining raw data of known wells; establishing relationship formulas between pore specific surface areas and adsorbed gas contents of a known well in an area as an adsorbed gas content quantitative prediction model; establishing relationship formulas between pore volumes and free gas contents of the known well as a free gas content quantitative prediction model; summing the adsorbed gas contents and corresponding free gas contents to obtain total gas contents; calculating adsorbed gas contents, free gas contents and total gas contents of the known wells; drawing a predicted adsorbed gas content contour map, a predicted free gas content contour map and a predicted total gas content contour map; and reading an adsorbed gas content, a free gas content and a total gas content of an unknown well in the area from the above contour maps.
Type:
Application
Filed:
October 17, 2024
Publication date:
April 24, 2025
Inventors:
Xinyang He, Kun Zhang, Hulin Niu, Chengzao Jia, Yan Song, Zhenxue Jiang, Shu Jiang, Xueying Wang, Nanxi Zhang, Xiaoxia Dong, Jun Dong, Ruisong Li, Tong Wang, Pu Huang, Jiasui Ouyang, Xingmeng Wang, Shoucheng Xu, Hanbing Zhang, Yubing Ji, Lei Chen, Xuefei Yang, Fengli Han, Weishi Tang, Jingru Ruan, Hengfeng Gou, Lintao Li, Yipeng Liu, Ping Liu
Patent number: 12263171
Abstract: In its many embodiments, the present invention provides certain 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives of Formula (I): or a pharmaceutically acceptable salt thereof, wherein ring A, R1, R2, and R4 are as defined herein, pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other therapeutic agents), and methods for their preparation and use, alone and in combination with other therapeutic agents, as antagonists of A2a and/or A2b receptors, and their use in the treatment of a variety of diseases, conditions, or disorders that are mediated, at least in part, by the adenosine A2a receptor and/or the adenosine A2b receptor.
Type:
Grant
Filed:
November 26, 2019
Date of Patent:
April 1, 2025
Assignee:
Merck Sharp & Dohme LLC
Inventors:
Yonglian Zhang, Amjad Ali, Jared Cumming, Duane DeMong, Qiaolin Deng, Thomas H. Graham, Elisabeth Hennessy, Matthew A. Larsen, Kun Liu, Ping Liu, Umar Faruk Mansoor, Jianping Pan, Christopher W. Plummer, Aaron Sather, Uma Swaminathan, Huijun Wang